GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Accounts Payable & Accrued Expense

Cessatech AS (XSAT:CESSA) Accounts Payable & Accrued Expense : kr3.14 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Accounts Payable & Accrued Expense?

Cessatech AS's quarterly accounts payable & accrued expense increased from Sep. 2024 (kr0.51 Mil) to Dec. 2024 (kr2.65 Mil) and increased from Dec. 2024 (kr2.65 Mil) to Mar. 2025 (kr3.14 Mil).

Cessatech AS's annual accounts payable & accrued expense declined from Dec. 2022 (kr3.72 Mil) to Dec. 2023 (kr1.79 Mil) but then increased from Dec. 2023 (kr1.79 Mil) to Dec. 2024 (kr2.65 Mil).

Cessatech AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cessatech AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Accounts Payable & Accrued Expense Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
0.20 4.41 3.72 1.79 2.65

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 1.28 0.51 2.65 3.14

Cessatech AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cessatech AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OSTO:XINT OSTO:GUARD OSTO:LIPUM OSTO:ACTI OSTO:ELIC OSTO:IVACC OSTO:XBRANE OSTO:KDEV OSTO:IRLAB A OSTO:IMMU VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
8GN:Germany
Address
Strandvejen 60, Hellerup, DNK, DK- 2900
Website
https://www.cessatech.com
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines